As pathologists, molecular geneticists, and physician scientists worked to precisely identify this tumor and differentiate it from its clinical, imaging, and histologic mimics, SMARCB1 (INI-1) immunohistochemistry proved to be a valuable diagnostic tool to diagnose AT/RT [5]. Here, SMARCB1 is linked to neoplasm.